Mar 28, 2023 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Evotec SE Preliminary Figures Full Year 2022 Call. (Operator Instructions) The presentation will be followed by a question-and-answer session. (Operator Instructions) I would now like to turn the conference over to Dr. Werner Lanthaler, CEO. Please go ahead.
Werner Lanthaler - Evotec SE - Chairman of Management Board & CEO
Thank you very much. A warm welcome from sunny Hamburg to all listeners. And let me first remind you that we have uploaded a presentation for this call, which you can find on the Internet, and we have called it Ahead of the Curve: Leadership in our Focus Areas for Medicines that Matter. This brings me directly into how we wanted to start this discussion with you today, because it is amazing to see what we have achieved in 2022, and let me start by thanking the whole company who is working every day to find new medicines that matter.
Let me also thank you, my closest team. It's a big pleasure and a great satisfaction to go forward with you also
Preliminary Q4 2022 Evotec SE Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers